The cholestasis-dependent increase of hepatic hydroxyproline content in Abcb4-/- mice appeared slightly reduced by ACEA and rimonabant treatment, but did not reach statistical significance (Figure 5E). The gene discussed is ABCB4; the disease is cholestasis.